Risk factors for late recurrent rejection after heart transplantation: a multiinstitutional, multivariable analysis. Cardiac Transplant Research Database Group.
S H Kubo(University of Minnesota), James K. Kirklin(Kirklin Clinic), Roger M. Mills(Janssen (Belgium)), R.J. Rodeheffer, John J. O’Donnell(University Hospital Galway), David C. Naftel(University of Alabama at Birmingham), Robert C. Bourge(University of Alabama at Birmingham), G Cintrón, Joseph L. Kenzora(Washington University in St. Louis)
PubMed
October 5, 1995
Cited by 148
Related Papers
Intravenous Nesiritide, a Natriuretic Peptide, in the Treatment of Decompensated Congestive Heart Failure
|New England Journal of Medicine|2000|908
Use of an Intrapericardial, Continuous-Flow, Centrifugal Pump in Patients Awaiting Heart Transplantation
|Circulation|2012|655
Reflex Increase in Coronary Vascular Resistance in Patients with Ischemic Heart Disease
|New England Journal of Medicine|1976|480
Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure
|Journal of the American College of Cardiology|1999|323
Nitroprusside in Critically Ill Patients with Left Ventricular Dysfunction and Aortic Stenosis
|New England Journal of Medicine|2003|278